GBP/IQD

Myriad Genetics (NASDAQ:MYGN) Price Target Lowered to $11.00 at Bank of America

03 Mar 2025 08:06:13 By Buzz FX

Bank of America Has Lowered Expectations for Public Service Enterprise Group (NYSE:PEG) Stock Price

03 Mar 2025 08:06:13 By Buzz FX

Sphere Entertainment (NYSE:SPHR) Releases Earnings Results, Misses Estimates By $1.34 EPS

03 Mar 2025 08:06:13 By Buzz FX

N-able (NYSE:NABL) Releases Earnings Results, Misses Expectations By $0.03 EPS

03 Mar 2025 08:06:13 By Buzz FX

AG Mortgage Investment Trust (NYSE:MITT) Posts Earnings Results, Misses Estimates By $0.01 EPS

03 Mar 2025 08:06:13 By Buzz FX

First Solar (NASDAQ:FSLR) Now Covered by Analysts at Redburn Atlantic

03 Mar 2025 08:03:14 By Buzz FX

Catalyst Pharmaceuticals (NASDAQ:CPRX) Price Target Raised to $32.00 at Robert W. Baird

03 Mar 2025 08:03:14 By Buzz FX

Robert W. Baird Issues Pessimistic Forecast for GitLab (NASDAQ:GTLB) Stock Price

03 Mar 2025 08:03:14 By Buzz FX

HC Wainwright Reiterates "Buy" Rating for Apellis Pharmaceuticals (NASDAQ:APLS)

03 Mar 2025 08:03:14 By Buzz FX

Janux Therapeutics (NASDAQ:JANX) Given "Buy" Rating at HC Wainwright

03 Mar 2025 08:03:14 By Buzz FX

Dow Jones Teeters Below Highs as Market Uncertainty Grows

03 Mar 2025 08:02:24 By Buzz FX

CyberArk Software (NASDAQ:CYBR) Given New $450.00 Price Target at Citigroup

03 Mar 2025 08:02:15 By Buzz FX

Middlesex Water (NASDAQ:MSEX) Rating Increased to Outperform at Robert W. Baird

03 Mar 2025 08:02:15 By Buzz FX

OPKO Health (NASDAQ:OPK) Receives Buy Rating from HC Wainwright

03 Mar 2025 08:02:15 By Buzz FX

Clover Health Investments (NASDAQ:CLOV) Price Target Raised to $4.50

03 Mar 2025 08:02:15 By Buzz FX

Fireweed Metals Corp. (CVE:FWZ) Director Buys C$225,000.00 in Stock

03 Mar 2025 08:02:15 By Buzz FX

Ascendiant Capital Markets Forecasts Strong Price Appreciation for Electronic Arts (NASDAQ:EA) Stock

03 Mar 2025 08:02:15 By Buzz FX

Robert W. Baird Issues Pessimistic Forecast for Novanta (NASDAQ:NOVT) Stock Price

03 Mar 2025 08:02:15 By Buzz FX

Iovance Biotherapeutics (NASDAQ:IOVA) Price Target Lowered to $30.00 at Chardan Capital

03 Mar 2025 08:02:15 By Buzz FX

Axsome Therapeutics (NASDAQ:AXSM) Price Target Raised to $160.00

03 Mar 2025 08:02:15 By Buzz FX